Product correctly added to cart.

No image
No image

c-Met/HGFR

c-Met/HGFR inhibitors target the Hepatocyte Growth Factor Receptor (c-Met), a tyrosine kinase involved in cellular processes such as growth, motility, and morphogenesis. c-Met signaling is implicated in cancer progression, metastasis, and resistance to therapies. Inhibiting c-Met can disrupt tumor growth and spread, making these inhibitors valuable in cancer research. At CymitQuimica, we offer c-Met/HGFR inhibitors to support your research in oncology, metastasis, and targeted cancer therapies.

Read more
Sort by


See more categories

This search does not contain any category.

products per page. 85 products on this category.

discount label

Canlitinib


Ref: TM-T78206

5mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Friday 7 Feb 2025
discount label

c-met-IN-1


Ref: TM-T10653

25mg1,688.00 €
50mg2,225.00 €
100mg2,897.00 €
Estimated delivery in United States, on Friday 7 Feb 2025
discount label

EGFR-IN-8


Ref: TM-T11162

1mg74.00 €
5mg166.00 €
10mg266.00 €
25mg440.00 €
50mg602.00 €
100mg825.00 €
Estimated delivery in United States, on Friday 21 Feb 2025
discount label

KRC-00715


Ref: TM-T200380

10mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Friday 7 Mar 2025
discount label

c-Met-IN-2


Ref: TM-T10654

25mg2,106.00 €
50mg2,785.00 €
100mg3,739.00 €
Estimated delivery in United States, on Friday 7 Mar 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".